JFG
PTCT icon

Jefferies Financial Group’s PTC Therapeutics PTCT Stock Holding History

Jefferies Financial Group’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,400
Closed -$369K – 1951
2023
Q4 		$369K Sell
13,400
-16,600
-55% -$380K ﹤0.01% 1321
2023
Q3 		$672K Buy
+30,000
New +$1.12M 0.01% 955

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jefferies Financial Group's PTCT Position: Q2 2026 in Review

Jefferies Financial Group increased its PTC Therapeutics (PTCT) stake by 0.19% in Q2 2026, buying an estimated $187K and bringing the position to 1,357,042 shares worth $111M. The position accounts for 0.73% of the portfolio, ranked #15.

Jefferies Financial Group first reported a position in PTCT in Q1 2023 and has held it in 11 quarters since. The position peaked at $126M in Q4 2025. 383 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Jefferies Financial Group held 1,357,042 shares of PTC Therapeutics worth $111M as of Q2 2026.
  • Jefferies Financial Group bought 2,583 PTC Therapeutics shares in Q2 2026, an estimated $187K.
  • PTC Therapeutics made up 0.73% of Jefferies Financial Group's portfolio in Q2 2026, its #15 holding.
  • Jefferies Financial Group first reported a position in PTC Therapeutics in Q1 2023 and has held it in 11 quarters since.
  • Jefferies Financial Group's PTC Therapeutics position peaked at $126M in Q4 2025.
  • 383 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.